Sunitinib for Treatment of Pancreatic Neuroendocrine Tumors: Patient-Reported Outcomes and Efficacy Across Patient Subgroups in a Phase III Trial Meeting Abstract

sustainable development goals

authors

publication date

  • March 1, 2011

webpage

published in

start page

  • 334

end page

  • 335

volume

  • 40

issue

  • 2